Form 4: Incyte Corp Executive Sells Shares to Cover Tax Obligations

An Incyte Corp executive sold shares to cover tax obligations related to the vesting of restricted stock units and performance shares.

Summary

• Barry P. Flannelly, an Executive Vice President and General Manager at Incyte Corp, sold 1,510 shares of common stock on December 9, 2024.
• The sale was executed at a price of $72.11 per share.
• The shares were sold to cover tax withholding obligations arising from the settlement of previously reported restricted stock units (RSUs) and earned performance shares.
• A total of 44,595 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares have not yet vested.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to executive compensation and tax obligations, which is neither positive nor negative for the company's overall outlook.

Industry Context

Executive stock sales for tax purposes are a common practice in publicly traded companies, particularly around vesting periods for equity-based compensation.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across the pharmaceutical and biotech industries.
• Companies like Regeneron, Gilead, and Amgen also see similar transactions by their executives.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a routine transaction.

Key Dates

Keywords

Incyte Corp, stock sale, executive, RSU, performance shares, tax obligations, vesting